The majority of reported double heterozygotes in the literature include BRCA1 and/or BRCA2, with only few studies and case reports describing double heterozygosity exclusively involving other BC risk genes, such as CHEK2, ATM, PALB2, NBS1, and BLM [36–44]. Here, CHEK2 is linked to breast cancer.